Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Researchers Develop Cancer-Targetting Hybrid Molecule

New York Researchers have developed a Hybrid Molecule that can target cancer cells, which they believe shows promise in the fight against breast cancer. The team created a composite nanoparticle that can transport chemotherapeutic agents, in a technique that more than doubled the uptake of an anti-inflammatory compound that inhibits cancer cell growth when directly applied to a tumor. The composite nanoparticle "can load up with these drugs, carry them to malignant cells, and unload them where they can do the most damage with the least amount of harm to the patient," according to a statement from the NYU Tandon School of Engineering, with one of the researchers summarizing it as a hybird molecule that "can carry higher payloads, enabling it to deliver more drug."

Share on Google+

Read more of this story at Slashdot.



This post first appeared on Werbung Austria - Slashdot, please read the originial post: here

Share the post

Researchers Develop Cancer-Targetting Hybrid Molecule

×

Subscribe to Werbung Austria - Slashdot

Get updates delivered right to your inbox!

Thank you for your subscription

×